JuneBrain

JuneBrain is a private, pre-revenue medical technology company founded in 2018 and headquartered in Bethesda, MD, with operations in Baltimore. The company is developing an integrated platform centered on portable, user-friendly OCT devices and AI-powered software for the quantitative analysis of retinal images, targeting applications in neurology (e.g., Multiple Sclerosis) and ophthalmology (e.g., Age-Related Macular Degeneration). Its business model combines the sale/investigational use of its Neuro-i SS-OCT device with a Reading Center service for clinical research, positioning it in the high-growth telemedicine and AI diagnostics markets. Recent investment from groups like the New Orleans BioFund and Gulf South Angels in March 2026 provides capital to advance its technology and commercial efforts.

Integrated platform of portable Swept-Source Optical Coherence Tomography (SS-OCT) hardware and AI-powered software for automated, quantitative analysis of retinal images to serve as biomarkers for neurological and retinal diseases.

JuneBrain competes with large medical device companies like Heidelberg Engineering, Zeiss, and Optovue that offer portable OCT systems, as well as numerous AI software startups analyzing retinal images. Its differentiation lies in its integrated hardware-software platform specifically designed for remote, quantitative neurology applications.